Antibodies to beta-interferons in multiple sclerosis - Can we neutralize the controversy?

被引：15
作者：
Cross, AH
Antel, JP
机构：
[1] Washington Univ, Sch Med, Dept Neurol & Neurosurg, Neuroimmunol Sect, St Louis, MO 63110 USA
[2] McGill Univ, Dept Neurol & Neurosurg, Neuroimmunol Unit, Montreal, PQ, Canada
来源：
NEUROLOGY | 1998年 / 50卷 / 05期
关键词：
D O I：
10.1212/WNL.50.5.1206
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1206 / 1208
页数：3
相关论文
共 13 条
[11]   Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis [J].
Rudick, RA ;
Simonian, NA ;
Alam, JA ;
Campion, M ;
Scaramucci, JO ;
Jones, W ;
Coats, ME ;
Goodkin, DE ;
Weinstock-Guttman, B ;
Herndon, RM ;
Mass, MK ;
Richert, JR ;
Salazar, AM ;
Munschauer, FE ;
Cookfair, DL ;
Simon, JH ;
Jacobs, LD .
NEUROLOGY, 1998, 50 (05) :1266-1272
[12]   Interferon beta induces interleukin-10 expression: Relevance to multiple sclerosis [J].
Rudick, RA ;
Ransohoff, RM ;
Peppler, R ;
Medendorp, SV ;
Lehmann, P ;
Alam, J .
ANNALS OF NEUROLOGY, 1996, 40 (04) :618-627
[13]   Immune-mediated side-effects of cytokines in humans [J].
Vial, T ;
Descotes, J .
TOXICOLOGY, 1995, 105 (01) :31-57
12